What Happened
TechCrunch reported that some AI startup founders are employing a dual-pricing valuation mechanism when raising capital. The practice involves selling the same class of equity at two different price points, effectively allowing companies to claim higher valuations than traditional single-price rounds would support.
The result: startups can manufacture unicorn status (the $1 billion+ valuation threshold) through financial structuring rather than purely through business fundamentals. The specific companies using this approach and the exact mechanics weren't fully detailed in the initial report.
Why It Matters
Valuations matter to AI tool users more than most people realize. When an AI startup raises at a $2 billion valuation, that number shapes expectations for revenue, pricing strategy, and growth trajectory. A company valued at unicorn levels needs to generate unicorn-level returns, which often means aggressive monetization of its user base.
We've already seen this play out. AI companies that raised at peak valuations in 2024-2025 have been steadily increasing prices, restricting free tiers, and pushing enterprise contracts. If startups are now inflating their valuations through financial engineering, the pressure to justify those numbers through pricing will only intensify.
For anyone evaluating AI tools for their workflow, this is relevant context. The tool you're adopting today might be priced for a $500M company's economics. If the company is actually carrying a $2B valuation manufactured through dual-price equity, expect the pricing roadmap to reflect the higher number.
Our Take
This is a red flag for the AI startup ecosystem, not because the mechanism is necessarily fraudulent, but because it signals that some companies can't achieve their target valuations through straightforward means.
The AI hype cycle has created enormous pressure to hit certain valuation milestones. VCs want to mark up their portfolios, founders want the recruiting and press advantages of unicorn status, and everyone involved has incentives to find creative ways to get there. Dual-price equity is the latest technique.
For tool buyers and individual users, the practical takeaway is simple: ignore valuations when evaluating AI tools. A $5 billion valuation doesn't mean the product is five times better than a $1 billion competitor. Focus on what the tool actually does, how reliable it is, and whether the pricing makes sense for your use case.
The companies building durable AI products will justify their valuations through revenue and retention, not financial engineering. When you see an AI startup trumpeting its unicorn status, ask what the revenue multiple looks like. That tells you far more about the product's future than the headline valuation number.